Screening for colorectal cancer in France. Experience in 165,000 people in the department of Calvados;LE DEPISTAGE DE MASSE DU CANCER COLORECTAL EN FRANCE. EXPERIENCE AUPRES DE 165000 PERSONNES DANS LE CALVADOS

Gastroenterologie Clinique et Biologique

Volumn 20, Issue 3, 1996, Pages 228-236

  Launoy, Guy ^a,b   Herbert, Catherine ^a   Vallée, Jean Pierre ^a   Desoubeaux, Nelly ^a   Réaud, Jean Marie ^a   Ollivier, Valérie ^a   Bouvier, Véronique ^a   Flachs, André ^a   Arsène, Dominique ^a   Valla, André ^a   Gignoux, Marc ^a  

^a Registre Cancers Digestifs Calvados ^*  (France)

^b UNIVERSITÉ DE CAEN   (France)

Author keywords

acceptability; colorectal cancer; participation; positive predictive value; public health; screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; SEX DIFFERENCE; ADENOMA; AGE; COLONOSCOPY; COLORECTAL TUMOR; MASS SCREENING; MIDDLE AGED; MORTALITY; OCCULT BLOOD; PREDICTION AND FORECASTING; RADIOGRAPHY;

ADENOMA; AGE FACTORS; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; FRANCE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; SEX FACTORS;

EID: 0029693392     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Launoy G, Grosclaude P, Pienkowski P, Faivre J, Ménégoz F, Schaffer P, et al. Les cancers digestifs en France. Comparaison de l'incidence dans 7 départements et estimation de l'incidence pour la France entière. Gastroenterol Clin Biol 1992;16:633-8
2. Sant M, Capocaccia R, Verdecchia A, Gatta G, Micheli A, Mariotto A, et al. Comparisons of colon-cancer survival among european countries: the Eurocare Study. Int J Cancer 1995; 63:43-8.
3. Hoff G, Foerseter A, Vatn MH, Sauar J, Larsen S. Epidemiology of polyps in the rectum and colon. Scand J Gastroenterol 1986;21:853-62.
4. Chantereau MJ, Faivre J, Boutron MC, Piard F, Arveux P, Bedenne L, et al. Epidemiology, management and prognosis of malignant large bowel polyps within a defined population. Gut 1992:33:259-63.
5. Toribara NW, Sleisenger MH. Screening for colorectal cancer. N Engl J Med 1995;332:861-7.
6. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Shuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 19:1365-71.
7. Hardcastle JD, Chamberlain J, Sheffield J, Balfour TW, Armitage NC, Thomas WM, et al. Randomised, controlled trial of fecal occult blood screening for colorectal cancer. Lancet 1989;1:1160-4.
8. Kronborg O, Fenger C, Olsen J, Bech K, Sondergaard O. Repeated screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol 1989; 24: 599-606.
9. Bedenne L, Durand G, Faivre J, Milan C, Boutron MC, Arveux P, et al. Résultats préliminaires d'une campage de dépistage de masse du cancer colorectal. Gastroenterol Clin Biol 1990;14:140-5.
10. Kewenter J, Bjork S, Haglind E , Smith L, Svanik J Anren C. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer 1998;62:645-51.
11. Pottier D, Launoy G, Le Coutour X, Dugleux G, Gignoux M. Importance de la définition des Zones Urbaines dans l'étude des facteurs de risque des cancers. Rev Epidemiol Sante Publique 1989;4:391-6.
12. Launoy G, Herbert C, Réaud JM, Maurel J, Thézée Y, Tichet Y, et al. Effect of the processing of Haemoccult test on the positive predictive value in mass screening for colorectal cancer. Br J Cancer 1995;72:1043-6.
13. Mandel JS, Bond JH, Bradeley M, Snover DC. Sensitivity, specificity and positive predictivity of the Hemocult test in screening for colorectal cancers. Gastroenterology 1989;97:597-600.
14. Winaver SJ, Baldwin M, Herbert E, Sherlock P. Screening experience with fecal occult blood testing as a function of age. In: Yannik R, ed. Perspective on prevention and treatment of cancer in the elderly. New York: Raven 1983:265-74.
15. Eide TJ. The age, sex, and site-specific occurrence of adenomas and carcinomas of the large intestine within a well-defined population. Scand J Gastroenterol 1986;21:1083-8.
16. Faivre J, Bedenne L, Boutron MC, Milan C, Collonge R, Arveux P. Epidemiological evidence for distinguishing subsites of colorectal cancer. J Epidemiol Comm Health 1989; 43:356-61.
17. Launoy G, Pottier D, Gignoux M. Cancer du côlon proximal et cancer du côlon distal, deux cancers épidémiologiquement différents. Gastroenterol Clin Biol 1989;13:255-9.
18. Moller Jensen B, Kronborg O, Fenger C. Interval cancers in screening with fecal occult blood test for colorectal cancer. Scand J Gastroenterol 1992;27:779-82
19. Whynes DK, Walker AR, Hardcastle JD. Effect of subject age on costs of screening for colorectal cancer. J Epidemiol Comm Health 1992;46:577-81.
20. Allemand H. Décisions éthiques et aspects socio-économiques de la prévention. Hepato-Gastro 1994;5:443-6.
21. Faivre J, Arveux P, Milan C, Durand G, Lamour J, Bedenne L. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study. Eur J Cancer Prev 1991;1:49-55.
22. Launoy G, Veret JL, Richir B, Réaud JM, Ollivier V, Valla A, et al. Involvement of general practitioners in mass-screening. Experience of a colorectal cancer mass-screening program in the Calvados region (France). Eur J Cancer Prev 1993;2:229-32.
23. Flachs A. Auto-évaluation de la dynamique de distribution du test Hémoccult II en pratique de Médecine Générale dans le cadre d'un dépistage de masse départemental. Gastroenterol Clin Biol 1995;19:457-8.
24. Myers RE, Balshem AM, Wolf TA, Ross EA, Miner L. Screening for colorectal neoplasia: physicians' adherence to complete diagnostic evaluation. Am J Public Health 1993;83:1620-2.
25. Dent OF, Bartrop R, Goulston KJ, Chapuis PH. Participation in fecal occult blood screening for colorectal cancer. Soc Sci Med 1983;17:17-23.
26. Silman A, Mitchell P. Attitudes of non-participants in an occupational based program of screening for colorectal cancer. Commun Med 1984;6:8-11.
27. Thomas W, White CM, Mah J, Geisser MS, Church T, Mandel JH. Longitudinal compliance with annual screening for fecal occult blood. Am J Epidemiol 1995;142:176-82.
28. Launoy G, Le Coutour X, Gignoux M, Pottier D, Dugleux G. Influence of rural environment on diagnosis, treatment and prognosis of colorectal cancer. J Epidemiol Comm Health 1992;46:365-7.
29. Lecomte T, Mizrahi AN, Mizrahi AR. Présentation de l'enquête nationale 1980-1981 sur les consommations médicales. Paris, CREDES, 1980.
30. Watt IS, Franks AJ, Sheldon TA. Health and health care of rural populations in the UK: is it better or worse? J Epidemiol Comm Health 1994;48:16-21.
31. Herbert C, Launoy G, Thézée Y, Maurel J, Richir B, Réaud JM, et al. Participants' characteristics in a French colorectal mass screening campaign. Prev Med 1995:24: 498-502.
32. Nichols S, Koch E, Lallemand RD Heald RJ, Izzard L, Machin D, et al. Randomised trial of compliance with screening for colorectal cancer. Br Med J 1986;293:107-10.
33. Faivre J, Tazi MA. Le rôle du médecin généraliste dans le dépistage des tumeurs colorectales. Gastroenterol. Clin Biol 1995;19:361-3.
34. Dubois G. Rapport au Ministre délégué àla Santé sur le dépistage du cancer du côlon et du rectum en France. Paris : 1994.